ImportantThis guide provides general information and cannot replace advice based on your pathology, scans and medical history.
High-dose-rate, or HDR, brachytherapy is a form of internal radiation in which a powerful radioactive source travels temporarily through applicators or catheters placed in or near a tumour. The source pauses at programmed positions for carefully calculated times and is then removed. No radioactive source remains after a typical HDR session.
Because radiation starts close to the target, dose can fall over a short distance. This may reduce exposure to some surrounding tissues compared with a less local approach, but it does not eliminate normal-tissue dose or side effects. The benefit and technique depend on the cancer site.
- The HDR source is temporary and controlled remotely.
- Applicator placement and three-dimensional planning are essential parts of treatment.
- Normal-tissue exposure is reduced where geometry allows, not eliminated.
- Anaesthesia, number of sessions and recovery vary by cancer site.
Where HDR brachytherapy is used
HDR brachytherapy is commonly used in cervical, endometrial, vaginal and prostate cancer and in selected breast, skin, head-and-neck or other settings. It may be the main local treatment, a boost after external-beam radiation or part of an organ-preserving strategy.
The applicator type and evidence differ considerably by site. A cervical intracavitary procedure and prostate interstitial implant share a source-delivery concept but are otherwise distinct clinical experiences.
How the applicator or catheters are placed
Applicators may sit within a body cavity, while interstitial catheters pass into tissue. Placement can use examination, ultrasound, CT, MRI or other guidance. Anaesthesia or sedation may be required, and some patients stay in hospital while the applicator remains in position.
The device must reproduce the intended geometry without injuring nearby structures. Tell the team about blood thinners, allergies, implanted devices, infection symptoms and anaesthetic history before the procedure.
Imaging and treatment planning
After placement, imaging shows the target, applicator and organs at risk. The team reconstructs the channels in planning software, selects source dwell positions and adjusts dwell times. For gynaecological brachytherapy, bladder, rectum, bowel and sigmoid dose may be evaluated; other sites have their own constraints.
This customised plan is a major reason brachytherapy cannot be reduced to simply putting radiation near the tumour. Applicator geometry, imaging quality, contouring and dose optimisation all influence the result.
What happens while radiation is delivered
Staff connect the applicator to an afterloader and leave the shielded room while maintaining audio and visual contact. The source moves through a transfer tube into the programmed channels. Delivery often takes minutes, though preparation and planning take much longer.
The patient must remain still. The source automatically retracts into the shielded unit when treatment finishes or if the system is interrupted. The applicator may then be removed or retained for another planned fraction.
Radiation safety and going home
After the source retracts, the patient is not radioactive from HDR treatment. Family members, children and pregnant people are not exposed by being nearby once the procedure is complete. This differs from some permanent-seed or low-dose-rate treatments that can require temporary precautions.
Discharge timing depends on anaesthesia, bleeding, pain, urinary function and the site treated. Follow written instructions on activity, catheter care, medicines and when to call the hospital.
Benefits, effects and questions about suitability
Potential advantages include conformal local dose and the ability to combine internal and external treatment. Effects may include temporary pain, bleeding, urinary or bowel symptoms and site-specific late effects. Procedure-related risks should be discussed separately from radiation effects.
Ask why HDR is preferred, whether an alternative technique is reasonable and how the total brachytherapy and external-beam doses work together. In cervical cancer, timely completion of the whole radiation course can be important, making coordination especially relevant.
How an individual consultation changes the answer
Online information describes patterns, not personal eligibility. A radiation oncology recommendation begins by confirming the pathology and stage, reviewing the actual scans and understanding previous treatment. The doctor then defines the intent: cure, reduction of recurrence risk, organ preservation, control of a limited metastatic site or relief of symptoms.
Your anatomy, symptoms, general fitness and priorities can change the balance between options that look similar on paper. Planning also reveals whether dose limits for nearby organs can be met. This is why a consultation may appropriately reach a different conclusion from a general article without either being contradictory.
A useful appointment should leave you able to explain what is being recommended, why it fits your case, what alternatives were considered, which uncertainties remain and what happens next. You do not need to decide during the first conversation if the situation is not urgent.
Turn general information into a useful medical discussion
Start by writing down the parts of this guide that appear relevant and the parts that do not match what you have been told. Do not use an online article to change medicines, skip an investigation or delay treatment on your own. Instead, ask the treating team to connect the general principle to your diagnosis, stage and treatment intent. If a term in the report is unclear, request the exact wording and an explanation in language you can repeat back.
Bring the pathology report, the actual CT, MRI or PET images as well as their written reports, operation notes, previous treatment summaries, current medicines and recent blood tests. Previous radiation needs special attention: a safe re-irradiation opinion may require the original digital plan, dose distribution and structure set, not only a discharge card. Sending records before the visit can leave more appointment time for decisions and questions.
It can help to create a one-page timeline with the biopsy date, major scan dates, surgery, medicine cycles and the recommendation currently being considered. Add your most important priorities, such as preserving an organ, reducing travel, maintaining work, fertility, urinary or bowel function, or understanding the chance of needing additional treatment. These priorities do not replace cancer-control considerations, but they help the doctor compare medically reasonable options in a way that fits your life.
Finally, distinguish urgent symptoms from decision questions. New weakness, severe bleeding, breathing difficulty, uncontrolled pain, confusion, fever or inability to drink may need prompt hospital assessment rather than a routine appointment or WhatsApp exchange. For a non-urgent decision, leave the consultation with a written next step, the expected time frame and a contact point for questions that arise after you review the discussion with your family.
Look beyond reassuring words and technology labels
Cancer information often uses words such as precision, advanced, targeted or minimally invasive. These terms can describe useful capabilities, but they do not prove that a treatment is appropriate or superior for one person. Ask what clinical problem a technique solves, what evidence supports it for your diagnosis and stage, and whether a simpler or different option could achieve the same goal. A machine brand, session count or dramatic dose image should never replace an explanation of treatment intent and expected benefit.
Useful comparisons include the complete pathway: preparation, other treatments, likely side effects, recovery, follow-up and the chance that additional treatment will be needed. Ask the clinician to separate common effects from rare serious risks and to state where evidence is strong, uncertain or based mainly on patient selection. If percentages are quoted, ask which group they came from and whether that group resembles your situation.
High-quality care also includes processes patients may not see: pathology and imaging review, contouring, peer discussion, physics quality assurance, image guidance, symptom support and a plan for anatomical change. These processes are less marketable than a machine name but often determine whether technology is used well. The best consultation should make the reasoning clearer, not simply make the treatment sound impressive.
Questions worth bringing with you
- Is brachytherapy essential to the curative plan?
- Will I need anaesthesia or admission?
- How many insertions and fractions are planned?
- Which organs limit the dose?
- Will any radiation remain in my body?
- What symptoms after discharge require urgent review?
Frequently asked questions
Am I radioactive after HDR brachytherapy?+
Not after the temporary source has returned to the afterloader and the applicator is removed or disconnected.
Is HDR brachytherapy painful?+
Radiation delivery is not normally felt, but applicator placement and remaining in position can cause discomfort and may require anaesthesia or pain control.
Is brachytherapy safer than external radiation?+
Neither is universally safer. They have different dose distributions, procedures and roles and may be used together.
These references support the general educational information above. They do not establish which treatment is appropriate for one person.
National Cancer Institute: Brachytherapy to Treat CancerTata Memorial Centre Guidelines for Toxicity Management in Oncology